Lupus nephritis drug completes successful clinical trials

Author: AKF staff  |  Posted:

An experimental drug used to treat patients with lupus nephritis has successfully completed clinical trials and its maker will seek approval from the U.S. Food and Drug Administration in 2020. If approved, it would be the first drug approved to specifically treat lupus nephritis. READ MORE >>

TOPICS: Research

FDA issues first approval for a diabetes medicine that slows progression of CKD

Author: AKF Staff  |  Posted:

For individuals living with diabetes—the leading cause of kidney failure—the approval by the U.S. Food and Drug Administration of the diabetes medicine canagliflozin (brand name INVOKANA®) to treat diabetic kidney disease and reduce the risk of hospitalization for heart failure patients with type 2 diabetes and diabetic kidney disease is cause for optimism. READ MORE >>

TOPICS: News, Research, Kidney disease prevention
Items 1 - 12 of 155  12345678910Next

Connect with Us